Ergoteles LLC Alkermes Plc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$28.34 - $33.63 $481,298 - $571,138
16,983 New
16,983 $531,000
Q4 2022

Feb 14, 2023
BUY
$21.94 - $26.24 $1.41 Million - $1.68 Million
64,211 Added 102.31%
126,971 $3.32 Million
Q3 2022

Nov 14, 2022
BUY
$22.0 - $31.87 $475,310 - $688,551
21,605 Added 52.5%
62,760 $1.4 Million
Q2 2022

Aug 12, 2022
BUY
$26.4 - $30.54 $1.09 Million - $1.26 Million
41,155 New
41,155 $1.23 Million

Others Institutions Holding ALKS

# of Institutions
372
Shares Held
175M
Call Options Held
140K
Put Options Held
143K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.9B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email